ETH 42
Alternative Names: ETH-42Latest Information Update: 19 Feb 2022
At a glance
- Originator ethris
- Developer Ethris
- Class RNA
- Mechanism of Action Protein synthesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Primary ciliary dyskinesia